Found: 11
Select item for more details and to access through your institution.
Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers—an Asian tertiary institution experience.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 11, p. 1, doi. 10.1007/s00520-024-08940-2
- By:
- Publication type:
- Article
Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition.
- Published in:
- Journal of Pathology, 2023, v. 259, n. 2, p. 194, doi. 10.1002/path.6032
- By:
- Publication type:
- Article
Decoding transcriptomic intra‐tumour heterogeneity to guide personalised medicine in ovarian cancer.
- Published in:
- Journal of Pathology, 2019, v. 247, n. 3, p. 305, doi. 10.1002/path.5191
- By:
- Publication type:
- Article
Recommendations to improve the clinical adoption of NGS‐based cancer diagnostics in Singapore.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 4, p. 222, doi. 10.1111/ajco.13339
- By:
- Publication type:
- Article
Limb Hypothermia for Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Study.
- Published in:
- Frontiers in Oncology, 2017, v. 6, p. 1, doi. 10.3389/fonc.2016.00274
- By:
- Publication type:
- Article
Update on immune checkpoint inhibitors in gynecological cancers.
- Published in:
- Journal of Gynecologic Oncology, 2017, v. 28, n. 2, p. 1, doi. 10.3802/jgo.2017.28.e20
- By:
- Publication type:
- Article
Low Levels of NDRG1 in Nerve Tissue Are Predictive of Severe Paclitaxel-Induced Neuropathy.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164319
- By:
- Publication type:
- Article
Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-05045-0
- By:
- Publication type:
- Article
DOMENICA study (GINECO-EN105b/ENGO-Ten13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1).
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 19, doi. 10.3802/jgo.2024.35.S2.P1
- By:
- Publication type:
- Article
A step towards the ambition of precision oncology in recurrent ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e64
- By:
- Publication type:
- Article